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ABSTRACT
The strength of peptide:MHC interactions with the T cell receptor (TCR) is 
correlated with the time to first cell division, the relative scale of the effector cell 
response, and the graded expression of activation-associated proteins like IRF4. To 
regulate T cell activation programming, the TCR and the TCR proximal kinase ITK 
simultaneously trigger many biochemically separate TCR signaling cascades. T cells 
lacking ITK exhibit selective impairments in effector T cell responses after 
activation, but under the strongest signaling conditions ITK activity is dispensable. 
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To gain insight into whether TCR signal strength and ITK activity tune observed 
graded gene expression through unequal activation of disparate signaling pathways, 
we examined Erk1/2 activation and NFAT, NF-κB translocation in naive OT-I CD8+ 
cell nuclei. We observed consistent digital activation of NFAT1 and Erk-MAPK, but 
NF-κB displayed dynamic, graded activation in response to variation in TCR signal 
strength and was tunable by treatment with an ITK inhibitor. Inhibitor-treated cells 
showed dampened induction of AP-1 factors Fos and Fosb, NF-κB response gene 
transcripts, and survival factor Il2 transcripts. ATAC-seq analysis also revealed 
genomic regions most sensitive to ITK inhibition were enriched for NF-κB and AP-1 
motifs. Specific inhibition of NF-κB during peptide stimulation tuned expression of 
early gene products like c-Fos. Together, these data indicate a key role for ITK in 
orchestrating optimal activation of separate TCR downstream pathways, specifically 
aiding NF-κB activation. More broadly, we revealed a mechanism by which variation 
in TCR signal strength can produce patterns of graded gene expression in activated 
T cells. 
INTRODUCTION
After T cell receptor (TCR) triggering, a single naïve CD8+ T cell has the 
potential to expand into millions of daughter effector cells which use cytolytic 
factors to eradicate virus-infected cells. The strength of the interaction between 
the TCR and cognate peptide:MHC molecules on antigen presenting cells (APCs) 
controls the rapidity the response and the ultimate scale of the effector pool. 
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Stronger-affinity TCR interactions lead to prolonged periods of proliferation and 
longer times of engagement with APCs, thereby producing larger pools of CD8+ 
effector T cells (1-3).
TCR triggering and proximal signaling events exhibit noisy, switch-like 
behavior (4). The kinetic proofreading model of TCR signal initiation posits that 
ligand discrimination is guarded by the accumulation of rate-limiting signaling 
intermediates which elicit committed activation of transcription factors. Strong 
peptide:MHC ligands bind frequently with the TCR and overcome these rate-
limiting steps, while weak ligands bind less frequently and are less likely to 
accumulate signaling intermediates (4-6). Individual downstream transcription 
factors pathways also display digital signaling behaviors. TCR-mediated store 
operated calcium (Ca2+) entry (SOCE) and subsequent nuclear factor of activated T 
cells (NFAT) activation display probabilistic, digital triggering corresponding to the 
dose of peptide:MHC (7-10). We recently demonstrated that NFAT1 nuclear 
translocation in response to TCR stimulation is a digital process, as Ovalbumin 
(OVA) peptide concentration modulates the frequency of responder cells within a 
naïve clonal OT-I T cell population, without affecting the amount of NFAT1 protein 
measured in individual responding cell nuclei (10). Similar bimodal behavior is 
described for extracellular signal-regulated kinase (Erk) activation, as OVA peptide 
dose carefully tunes the number of digitally activated Erk responders in a pool of 
naïve OT-I cells (11, 12). The behavior of these pathways is enforced through 
feedback mechanisms (Erk) and rapid regulation of phosphorylation states (NFAT) 
(8, 12). Nuclear factor (NF)-κB signaling in T cells has also been observed to behave 
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digitally under some conditions (13). Following TCR engagement, these separate 
pathways activate in concert. However, careful observation of the simultaneous and 
relative behavior of each pathway in T cells in response to peptide stimulation is 
lacking (14). 
 Peptide concentration and avidity contribute to the probability of digital TCR 
triggering in individual cells, but at the same time these same variables tune the 
graded expression of important effector-associated factors, notably interferon 
regulatory factor (IRF)4 and CD25 (10, 12, 15, 16). This disconnect prompted us to 
question how graded gene expression patterns emerge from digital signaling 
events. Interleukin-2-inducible T cell Kinase (ITK) is a critical component for 
optimal activation of phospholipase-C-gamma (PLCγ), the enzyme that cleaves the 
membrane-embedded phosphatidylinositol bisphosphate (PIP2) into equimolar 
amounts of two second messengers: inositol triphosphate (IP3) and diacylglycerol 
(DAG). IP3 and DAG are responsible for robust activation of downstream TCR 
signaling pathways including NFAT, Erk, and NF-κB (17, 18). Although TCR signaling 
is not completely abolished in the absence of ITK, T cells from Itk-/- mice show 
inefficient intracellular Ca2+ flux and have notable defects in Erk phosphorylation 
(p-Erk) (19-22). Stimulation of naïve Itk-/- OT-I cells or treatment with a small 
molecule ITK inhibitor limited the induction of IRF4 (15), indicating that ITK may not 
regulate gene expression in an all-or-none fashion, but rather act as a rheostat to 
carefully tune TCR signaling.
To determine whether ITK differentially regulates digital TCR responses to 
tune graded gene expression, we measured simultaneous NFAT1, NF-κB and Erk 
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activation in single naïve OT-I T cells stimulated with peptides of variable affinity 
with or without use of an inhibitor of ITK (and resting lymphocyte kinase, RLK). We 
found that NFAT1 and Erk activation reliably responded digitally, including in weakly 
stimulated cells, however each pathway has a different sensitivity to ITK/RLK 
inhibition. Importantly, NF-κB activation occurred incrementally; cells that digitally 
triggered NFAT1 had graded amounts of NF-κB activation that scaled with peptide 
affinity and was sensitive to ITK/RLK inhibition. We also measured the immediate 
transcriptional response following different TCR signaling conditions which 
revealed expression of NF-κB target transcripts and AP-1 factors were most 
sensitive to ITK/RLK-inhibition. Regions of changing DNA accessibility most 
sensitive to ITK/RLK inhibition were also enriched for NF-κB and AP-1 binding 
motifs. Inhibition of NF-κB activation in stimulated OT-I cells altered TCR-induced 
gene expression in a pattern that mirrored the effects ITK/RLK inhibition. 
Together, these data underscore a role for ITK as an amplifier of TCR signaling; 
critical to tune NF-κB signaling in digitally-activated naïve CD8+ T cells. 
MATERIALS AND METHODS 
Mice 
Mice were bred and housed in a specific pathogen-free facility at the University of 
Massachusetts Medical School (Worcester, MA) in accordance with Institutional 
Animal Care and Use Committee guidelines. OT-I transgenic Rag1-/- mice 
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(B6.129S7-Rag1tm1Mom Tg(TcraTcrb)1100Mjb N9+N1) and C57BL/6 wild type mice were 
purchased from Taconic Biosciences. CD45.1+ (B6.SJL-PtprcaPep3b/BoyJ) mice 
were purchased from The Jackson Laboratory. Unless otherwise noted, 
experimental cohorts consisted of age and sex-matched littermates aged 6-12 
weeks. 
  
Stimulation of CD8+ T cells 
Freshly harvested OT-I Rag1-/- mouse splenocytes were pooled, RBC lysed, and 
enriched for CD8+ cells with an EasySep™ negatively selective magnetic isolation 
kit (STEMCELL Technologies). OT-I cells prepared for use in nuclei isolation 
experiments were then treated with CellTrace™ Violet reactive dye (Invitrogen) for 
20 minutes to fluorescently label cells (including nuclei). OT-I cells were cultured at 
2 x 105 cells per well (unless otherwise noted) and incubated with or without 50 nM 
(or otherwise noted) ITK/RLK inhibitor PRN694 (Principia Biopharma) for 30 
minutes 37˚C. In some experiments, OT-I cells were incubated with or without IKK 
inhibitor IKK-16 (Sigma) or MEK inhibitor PD325901 (Tocris Bioscience). For 
antigen-presenting cells, RBC-lysed splenocytes harvested from wild type mice 
were cultured at 4 x 105 per well and incubated with indicated concentrations of 
OVA “N4” peptide (SIINFEKL), altered OVA “T4” peptide (SIITFEKL), altered OVA “G4” 
peptide (SIIGFEKL) (21st Century Biochemicals) for 30-60 minutes at 37˚C. OT-I cells 
and peptide loaded splenocytes were then combined and incubated at 37˚C for 
specific times. For cell preparations used for molecular analyses (e.g. RNA-seq and 
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ATAC-seq analyses), splenocytes from CD45.1+ wild type mice were used as peptide 
presenting cells for easy exclusion from CD45.2+ OT-I cells via cell sorting. 
Nuclei isolation 
To measure translocation of nuclear proteins, we isolated cell nuclei after 
stimulation for fixation and subsequent flow cytometry analysis. To do this, we 
utilized a sucrose buffer-based protocol that we and others have previously 
published (7, 10). To summarize, stimulated cells were pelleted and washed with 200 
µL of ice cold “Buffer A” containing 320 mM sucrose, 10 mM HEPES (Life 
Technologies), 8 mM MgCl2, 13 EDTA-free cOmplete Protease Inhibitor (Roche), and 
0.1% (v/v) Triton X-100 (Sigma-Aldrich). After 15 min on ice, the plate was spun at 
2000 x g and 4°C for 10 min. This was followed by 2X 200 µL washes with “Buffer 
B” (Buffer A without Triton X-100) at 2000 x g and 4°C. 
  
Antibodies and flow cytometry 
Stimulated cells and isolated cell nuclei were fixed and permeabilized with the 
Foxp3 / Transcription Factor Staining Buffer Set (eBioscience), except cells used for 
anti-p-Erk1/2 analysis, which were fixed with 4% paraformaldehyde (Electron 
Microscopy Services) and permeabilized with 90% ice-cold methanol (FisherSci). 
Fluorescently-labeled flow cytometry antibodies against IRF4 (3E4), CD69 (H1.2F3), 
and Egr2 (erongr2) were purchased from eBioscience. Antibodies against CD8a 
(53-6.7), CD8b (53-5.8), CD25 (3C7), CD90.2 (53-2.1), p-Erk1/2 (4B11B69) were 
purchased from BioLegend. Antibodies against NFAT1 (D43B1), NF-κB p65 (D14E12), 
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c-Fos (9F6), and c-Myc (D84C12) were purchased from Cell Signaling Technology. 
Anti-CD45.1 (A20) was purchased from BD Pharmingen. PE-conjugated F(ab')2-goat 




Samples of stimulated CD45.2+ OT-I cells and CD45.1+ wild type splenocytes 
mixtures were stained with CD8a and CD45.2 antibodies and 7-AAD and OT-I cells 
were sorted (BD FACSAria) into 100% FBS and pelleted. 
  
RNA-seq library preparation 
Total RNA from ~300,000 OT-I cells per sample was collected with the RNeasy 
micro kit (Qiagen) with a 15-minute on-column DNase digestion (Qiagen) to remove 
genomic DNA. Total RNA quality and quantity was determined with fragment 
analysis (University of Massachusetts Medical School Molecular Biology Core Lab) 
and Qubit Fluorometer (Invitrogen) analysis. cDNA libraries were generated 
following a modified paired-end SMART-seq protocol (23, 24). Briefly, at least 20 ng 
of input RNA was used for reverse transcription with SMARTscribe reverse 
transcriptase (Clontech). Whole transcriptome amplification (WTA) was performed 
with Advantage 2 polymerase (Takara Bio). WTA reactions were monitored with 
qPCR to determine optimal cycle number. WTA libraries were then sized-selected 
with AMPure XP DNA SPRI beads (Beckman Coulter), tagmented with Tn5 
transposases (Illumina Nextera XT), barcoded, and amplified with cycle number 
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determined via qPCR monitoring. Final libraries were further size-selected with 
SPRI beads to an average size of 300-500 bp and quality was assessed with 
fragment analysis and Qubit analysis. Libraries were pooled and sequenced on a 
NextSeq 500 sequencer (Illumina). 
  
Processing and analysis of RNA-seq reads 
Adapter sequences were trimmed from quality raw sequencing reads with 
Trimmomatic-0.38 (25) and then aligned to mouse ribosomal RNA with Bowtie2 
v2.3.2 (26). Unaligned reads were retained, and gene expression was estimated 
(transcripts per million and expected counts) with RSEM v1.2.29 (27) configured to 
align to a mm10 RefSeq transcriptome with Bowtie2 v2.3.2. Samples were filtered to 
retain expressed genes (expected counts > 200) and batch effects between 
replicates were corrected with limma v3.42.2 (28). Differential expression analysis 
was performed with DESeq2 v1.26.0 (29) to identify induced genes (stimulated 
conditions vs. unstimulated controls) or condition-specific changes in expression 
(untreated vs. PRN694 or N4 vs T4 OVA peptides). Hierarchical clustering and k-
means clustering of differentially expressed genes was performed within R v3.5. 
Heatmap visualizations of gene clusters were drawn with ComplexHeatmap (30). 
  
Gene ontology 
We utilized the R package msigdbr v7.0.1 to compare clusters of differentially 
expressed genes with the Molecular Signatures Database (MSigDB) Hallmark (H) 
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and Immunologic (C7) gene sets (31-33). The top five terms with FDR <0.05 were 
displayed in the Results. 
  
ATAC-seq library preparation 
Precisely 50,000 stimulated OT-I T cells were FACS sorted at the same time as 
RNA-seq samples and pelleted in 100% FBS. ATAC-seq libraries were generated 
similarly as described in Buenrostro et al., 2013 (34). Briefly, cell nuclei were isolated 
and transposed with 8 µL Tn5 (Illumina Nextera) at 37˚C for 60 minutes. DNA 
fragments were isolated with a Clean and Concentrator Kit (Zymo) and then 
Illumina barcoded and amplified with NEBNext High-Fidelity 2x PCR Master Mix 
(New England Biolabs). A portion of the reaction was performed as a separate qPCR 
reaction to determine ideal cycle number. Samples were then size selected with 
SPRI beads to include fragments up to 450 bp, ensuring to maintain small (<200 bp), 
nucleosome-free fragments. Quality of final ATAC-seq libraries was assessed with 
fragment analysis and Qubit analysis. Libraries were then pooled and sequenced on 
an Illumina NextSeq 500. 
  
Alignment and processing of ATAC-seq reads 
Adapter sequences were trimmed from raw sequencing reads with Cutadapt v1.3 
(35) and then aligned to the mouse genome (mm10) with Bowtie2 v2.1.0 with the 
parameter -X 2000. PCR duplicates were removed with Picard’s markDuplicates 
v2.17.8 and aligned reads were sorted and filtered with SAMtools v1.4.1 (36). For 
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Aligned ATAC-seq reads were trimmed to 29 bases closest to the Tn5 cut site with 
bedtools v2.26.0 (39) and then peaks were called with MACS2 v2.1.1 (40) using 
parameters --bw 29 --nomodel -q 0.0001. Summits of called peaks across all 
samples were merged and “slopped” ±100bp to create a master peak reference file 
using bedtools v2.26.0. Peaks were annotated with names of closest genes using a 
mouse OT-I TSS BED file and bedtools v2.26.0 (closest -D ref -t all). Peaks with 
summits within 500 bp from TSSs were labeled “promoter” peaks and summits 
further than 500bp were labeled “enhancer” peaks. Peak coverage for each ATAC-
seq sample was calculated using bedtools v2.26.0 (intersect; coverage). 
  
Differential Peak Analysis 
Calculated peak coverage values for two ATAC-seq replicate experiments were used 
as input for differential analysis using DESeq2 v1.26.0. All differential peaks 
(compared to unstimulated controls) were clustered using either hierarchical or k-





Each cluster of annotated differentially accessible peak regions was tested for de 
novo motif enrichment using HOMER v4.10.3 (findMotifsGenome.pl -size 200) with 
background comprised of peak regions found in all other clusters (41). 
  
Genomic Visualizations 
Genomic tracks were created by plotting BigWig files with help of Gviz (42) PMA 
and ionomycin ATAC-seq tracks and NF-κB ChIP-seq tracks were extracted from 
publicly available sources (43, 44). 
RESULTS 
 Signaling pathway activation after TCR engagement has largely been 
described as digital, where TCR triggering is guarded by a threshold for activation 
and downstream responses of NFAT, NF-κB and MAPK then “switch on” together (9, 
12, 13). The probability that a TCR stimulus will digitally activate an individual naïve 
T cell within a stimulated clonal population is measured by examining the fraction 
of cells that upregulate the cell surface marker CD69 (11, 12, 16, 18). Cells 
experiencing weakened TCR stimulation may sufficiently switch on digital CD69 
expression but fail to maximally upregulate important effector-associated factors 
like IRF4 (16). Additionally, CD69 expression does not explicitly guarantee that a T 
cell will be sufficiently stimulated to commit to clonal expansion and effector 
programming (45, 46). Thus, there are signaling behaviors underlying digital 
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triggering that generate divergent gene expression programs and ultimately 
contribute to a naïve T cell’s fate. We hypothesized that the activity of the TCR 
proximal tyrosine kinase ITK is sensitive to variable amount of TCR stimulation in 
order to tune the intensity of downstream signaling pathways and the graded 
transcription of a subset of genes induced in digitally activated cells. 
ITK/RLK inhibition differentially dampens gene expression in 
activating OT-I cells. 
 To test whether tunable ITK activity modulates TCR signaling during 
activation, we measured gene expression in CD8+ T cells treated with a covalent 
small molecule inhibitor (PRN694) (47). PRN694 is a compound highly selective for 
the active site of both ITK and Resting Lymphocyte Kinase (RLK); RLK is a kinase 
co-expressed in naïve T cells structurally similar to ITK without clear function in 
TCR signaling (48). Thymically-derived Itk-/- cells do not develop normally (22). 
Thus, PRN694 allows for titrated control of ITK/RLK activity in naive wild-type OT-
I cells and assures both untreated and treated naïve cell transcriptional states are 
similar before stimulation. To regulate TCR signaling via differential ligand 
stimulation, we utilized OVA peptide plus altered peptide ligands, where graded 
peptide potency is achieved using residue substitutions within the native ‘SIINFEKL’ 
OVA peptide (N4) (2). After stimulation with weaker affinity ‘SIITFEKL' (T4) altered-
OVA peptide, a similar number of ITK/RLK inhibitor-treated and untreated OT-I 
CD8+ T cells upregulated CD69, but inhibitor-treated cells exhibited dampened 
expression of IRF4 (Fig. 1A). This confirmed that the ITK/RLK inhibitor has a 
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differential effect on specific activation-induced genes, similar to studies examining 
Itk-/- OT-I cells (16). Inhibitor-treated T4-stimulated cells also displayed less 
proliferative potential measured at 48hrs, with a large percentage of cells remaining 
undivided (Fig. 2B). Thus, under these conditions ITK/RLK activity is dispensable 
for switch-like induction of the activation marker CD69, but critical in tuning the 
intensity of other important genes that govern T cell activation programming and 
division.
NF-κB activation is tunable in digitally activated naive OT-I cells. 
 Pathways downstream of the TCR critical for robust T cell activation are 
highly dependent on the activation of NFAT, NF-κB, and AP-1 transcription factor 
families (18, 49, 50). We hypothesized that each pathway may have different 
sensitivity to varied amounts of upstream TCR stimulation or ITK activity and 
differential signaling patterns could contribute to graded expression of activation 
associated factors. Naïve cells have NFAT and NF-κB factors sequestered in the 
cytoplasm such that TCR engagement induces their rapid translocation to the 
nucleus (50, 51). To measure activation of NFAT and NF-κB in single cells, we 
performed flow cytometry with stimulated OT-I nuclei, as described previously (10). 
This technique allowed us to quantify both the proportion of OT-I cells responding 
to stimulation as well as the relative abundance of each factor within individual 
stimulated nuclei.
After strong peptide:MHC stimulation, we observed that NFAT1 and NF-κB 
(p65) quickly translocated to the nucleus (Fig. 1C). Erk-MAPK signaling was also 
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rapidly activated in nearly all stimulated OT-I cells, as measured by conventional 
phospho-Erk1/2 (p-Erk) fluorescence. These rapid responses confirmed previously 
reported “switch-like” signaling behavior after TCR engagement (7, 10-13). However, 
in response to weaker peptide stimulation, differences between pathways became 
more evident. Stimulation with T4 altered OVA peptide produced slower 
accumulation of the OT-I population exhibiting nuclear NFAT1 and p-Erk, and also 
reduced the maximum proportion of NFAT1 positive nuclei by 2 hours of stimulation 
from ~90% to 75% (Fig. 1D-F). Importantly, we observed minimal differences in 
NFAT1 or p-Erk MFI within responding nuclei or cells, indicating that these 
pathways remained digitally triggered even under weaker signaling conditions (Fig. 
1D). In contrast, TCR stimulation with T4 peptide failed to optimally activate NF-κB, 
as evident by both the reduced number of responder cells and, by a lower intensity 
of NF-κB fluorescence in single OT-I nuclei (Fig. 1D). Intermediate intensity of 
nuclear NF-κB-p65 suggested that TCR control of the NF-κB pathway did not 
behave digitally, as was observed for NFAT1 and p-Erk1/2 activation. Furthermore, 
compared to chemical activation with PMA and ionomycin, peptide:MHC stimulated 
OT-I cells activated NF-κB with suboptimal intensity, while NFAT1 activation in the 
same cell nuclei was similar between the two stimulation conditions (Fig. 1E). These 
findings demonstrated that under more physiological peptide stimulation 
conditions, NF-κB is more tunable to the level of TCR engagement than NFAT1 and 
p-Erk and revealed a dynamic range of activation states within a population of 
stimulated T cells.
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ITK/RLK inhibition selectively dampens NF-κB intensity in 
activating OT-I cells.
To test whether NF-κB activation was tunable by relative levels of ITK 
activity, we treated OT-I cells with the ITK/RLK inhibitor PRN694 prior to 
stimulation with peptide:MHC, and then measured patterns of NFAT1 and NF-κB 
(p65) translocation or p-Erk1/2 induction. During N4 OVA peptide stimulation, 
ITK/RLK inhibitor treatment had little effect on NFAT1 and p-Erk1/2 activation, but 
led to a marked reduction in the intensity of NF-κB activation (Fig. 1F,G). Notably, 
NF-κB MFI was reduced in cells that had a similar amount of NFAT1 fluorescence as 
those from the untreated samples (Fig. 1G). NF-κB MFI was also more sensitive to 
incremental doses of PRN694 within NFAT1-positive nuclei (Fig. 1H). During 
stimulation with T4 peptide, inhibitor-treated cells had weakened NFAT1, p-Erk1/2, 
and NF-κB activation (Fig. 1F-H). Various concentrations of strong N4, weak T4, or 
even weaker G4 peptide indicated that NF-κB activation was consistently sensitive 
to PRN964 treatment, while NFAT1 activation was less sensitive to PRN694, 
especially during strong N4 stimulation conditions (Supplemental Fig. 1). We 
interpreted the global effect of the inhibitor during weaker signaling as dilating the 
temporal window during which cells “switched on” along with lowering the absolute 
probability, or threshold, of activation. ITK/RLK inhibition mirrored the effect of 
varying TCR stimulation with weakened affinity peptides.  
 While NFAT activation is directly influenced solely by activation of 
calcineurin, NF-κB can be regulated by both DAG activation of IKK complex 
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proteins as well as Ca2+ activation of CaM kinases (49, 52, 53). As ITK activity is 
upstream of both DAG and Ca2+, it could possibly have multifactorial control over 
NF-κB. To separate DAG and Ca2+ components of NF-κB activation in OT-I cells, 
PMA or ionomycin was supplemented to wells of OT-I cultures during N4 
stimulation with or without PRN694. Ionomycin addition to cultures during N4 
stimulation did not modify the NFAT1+ fraction (which was already >90% 
responders) or modulate the NFAT1 fluorescence intensity, but did increase the 
proportion NFAT1 responders during T4 stimulation as expected (Fig. 2A-B). 
Ionomycin alone (in the absence of peptide stimulation) was sufficient to maximally 
translocate NFAT1, but did not induce appreciable NF-κB translocation (Fig. 2A). 
Ionomycin supplementation during N4 or T4 peptide stimulation increased NF-κB 
(p65) fluorescence intensity within individual nuclei, indicating the threshold of 
Ca2+ flux sufficient to translocate NFAT1 is not the same as the maximum 
contribution to NF-κB translocation. PMA supplementation maximized NF-κB (p65) 
translocation in N4 or T4 stimulated cells and easily recovered the defect in NF-κB 
signaling due to ITK inhibition with PRN694. These experiments demonstrated that 
under physiological peptide stimulation, separate downstream pathways are 
differently sensitive to the secondary messengers generated from the results of ITK 
activity. They also highlighted the synergistic nature of Ca2+ and DAG signaling in 
NF-κB activation, but showed a dominant role for amounts of DAG, rather than Ca2+, 
to tune translocation. 
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 These data demonstrated the complex behavior of concomitant signaling 
pathways in response to variable TCR inputs. We concluded that pathways such as 
NFAT1 and MAPK require a lower threshold of TCR stimulation to activate digitally, 
whereas NF-κB can be triggered rapidly (and appear digitally switched) under 
supra-physiological TCR engagement, but normal peptide stimulation taps into a 
dynamic range of NF-κB activation states. Also, ITK activity is crucial in ensuring 
optimal activation of graded NF-κB, which sheds light on the role ITK as an 
amplifier of TCR signals.
ITK/RLK inhibition dampens NF-κB-associated gene expression 
immediately following TCR engagement
As we observed that NF-κB activation was more sensitive to ITK/RLK 
inhibition, we hypothesized that variable NF-κB intensity within activated cells 
might contribute to immediate transcriptional control of graded gene induction. 
Prior to upregulation of effector genes like IL-2 and IRF4, activating CD8+ T cells 
undergo waves of primary and transient gene transcription (54-56). To connect 
observed differential signaling behavior in naïve T cells to immediate 
transcriptional effects, we treated OT-I cells with or without ITK/RLK inhibitor and 
briefly stimulated with OVA N4 and altered OVA T4 peptide presented on wild type 
splenocytes. We then sorted OT-I cells and measured transcript abundance with 
RNA sequencing.
To determine whether varying peptide affinity or modulating ITK activity 
regulated disparate transcriptional programming, we compared transcripts 
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upregulated in N4 or T4 stimulated OT-I cells, with or without treatment with ITK/
RLK inhibitor at 30, 60, and 120 minutes of activation. We observed that each 
condition, testing different qualities of TCR signaling, induced sets of transcripts 
largely similar in composition, but significantly different in abundance (Fig. 3A-B, 
Supplemental Fig. 2, Supplemental Fig. 3). While a subset of transcripts that were 
identified in N4 stimulated cells were not significantly upregulated in T4 stimulated 
cells, we found very few genes upregulated in T4-stimulated cells that were not 
seen in N4 stimulated cells (Supplemental Fig. 3). We clustered genes induced over 
two hours into six groups (Fig. 3A-B). Gene clusters that exhibited peak expression 
30 minutes after TCR contact with peptide:MHC were enriched for TCR signaling-
related ontology terms, including “AP-1 signaling,” “NF-κB signaling,” and “NFAT 
signaling” (Fig. 3C). This suggested that TCR downstream signaling pathways 
directly regulate transcription of these immediate early genes. Clusters of delayed 
genes first detectable at times greater than 30 minutes were enriched for terms 
linked to T cell effector functions, “Myc targets,” and cell cycle regulation, 
representing secondary gene transcription responses beyond direct TCR control, 
and likely regulated by a mix of continuing TCR signaling and first wave gene 
transcription. These experiments allowed us to interrogate the immediate 
transcriptional response to TCR engagement and revealed that modulation of 
upstream TCR signal strength activates overall similar transcriptional programming.
To determine whether weakened NF-κB activation during ITK/RLK inhibition 
differentially regulated the abundance of immediately induced transcripts, we 
compared differentially expressed transcripts in OT-I cells treated with or without 
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inhibitor after 30 minutes of strong N4 peptide stimulation. Among transcripts 
significantly diminished by the ITK/RLK inhibitor were induced AP-1 family 
members (Fos, Fosl1, Fosb, Jun) and NF-κB response genes (Nfkbia, Nfkbid, Nfkbiz, 
Tnfaip3) (Fig. 4A). We interpret these results as reflecting the effect of weakened 
NF-κB signaling in ITK inhibited cells. Genes that were upregulated compared to 
unstimulated cells but were less sensitive to ITK/RLK inhibition included Egr family 
transcripts (Egr1, Egr2, Egr3) and the activation marker CD69 (Fig. 4A). After 2 hours 
of stimulation, ITK/RLK inhibitor-treated OT-I T cells also had significantly lower 
expression of cytokines (IL2, Ifng) and effector associated transcripts (Irf4), which is 
expected based on the known importance of ITK signaling in conferring robust 
effector functions (Supplemental Fig. 4) (57-59). Independent of TCR stimulus, most 
immediately-induced transcripts (e.g. Fos, Fosb, Fosl1, Egr1, Egr2) peaked in 
abundance 30 minutes after contact with peptide:MHC (Fig. 3A-B, 4A, Supplemental 
Fig. 4). This window of transcription is a known pattern of immediate-early gene 
regulation (55, 56). Our RNA-seq experiments did not suggest that ITK/RLK 
inhibitor caused delayed induction of these genes in strongly-stimulated OT-I cells, 
but effects of this type might be revealed by further single cell expression analysis 
approaches. 
Changes in DNA accessibility sensitive to ITK/RLK inhibitor are 
enriched for NF-κB and AP-1 motifs.
To connect individual TCR signaling pathway behavior with ITK control of 
immediate gene expression patterns, we measured immediate, genome-wide DNA 
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accessibility changes with ATAC-seq and analyzed enrichment of transcription 
factor binding motifs using HOMER (34, 41). Cells for ATAC-seq analysis were sorted 
at the same time as those used in RNA-seq experiments, to better compare 
accessibility changes with gene expression. ATAC-seq replicates clustered together 
when plotted with PCA, indicating that variance was attributed to differences in 
stimulation. Similar to patterns found in transcriptome analysis, the strength of the 
TCR stimulation or ITK inhibition did not regulate an independent set of genomic 
regions, but rather regulated the intensity of a shared set of activation-associated 
pileups (data not shown). Compared to naive, unstimulated OT-I cells, strong N4 
stimulation induced the most significant differences in DNA accessibility, most 
evident after 120 minutes (Fig. 5A). After only 30 minutes of N4 stimulation, about 
10,000 DNA regions displayed differential accessibility compared to unstimulated 
cells (Fig. 5B). To evaluate differential accessibility due to ITK inhibition, N4 
stimulated cells with and without ITK inhibition were compared. After 30 minutes 
of stimulation, the most significant changes in accessibility due to PRN694 were 
found near many gene loci also identified in early transcriptional data including 
AP-1 factors (Fosb, Jun), NF-κB response genes (Nfkbia, Nfkb1), and genes encoding 
transcription factors important in regulating effector function (Rel, Nfatc1, Irf4) (Fig. 
5C). This indicated that while many genomic regions change in accessibility 
similarly during activation, the few that were most sensitive to PRN694 also were 




 Similar to the RNA-seq experiments, the strength of the TCR stimulation or 
ITK/RLK inhibition did not regulate an independent set of genomic regions, but 
rather regulated the intensity of a shared set of activation associated pileups (Fig 
5E-F). k-means clustering of all 30 minute activation-induced DNA accessibility 
changes (differentially-accessible compared to unstimulated control) for all sample 
conditions revealed regulation of regions that had increased dependency on ITK 
activity (Fig. 5D). Regions that were less accessible after treatment with the ITK/
RLK inhibitor were significantly enriched for AP-1 (“Fra1”) motifs and NF-κB motifs. 
Regions that were less sensitive to PRN694 treatment were significantly enriched 
for NFAT family motifs. The ATAC-seq results indicate that specific DNA regions 
were differentially more reliant on ITK activity for optimal regulation. Based on the 
motif enrichment data, we interpreted these accessibility changes to be due to, at 
least in part, decreased NF-κB signaling in ITK/RLK-inhibited cells. 
TCR stimulus and ITK regulate graded selective expression of early 
gene products 
 To determine whether ITK/RLK inhibitor-specific effects on immediate 
transcription also led to reduced protein product accumulation during activation, 
we measured Egr2, c-Fos, c-Myc intracellular content in stimulated cells via flow 
cytometry (Fig. 6A-C). Both c-Fos and Egr2 proteins were detectable within 30 
minutes after OVA stimulation. Treatment with the ITK/RLK inhibitor dampened 
the amount of c-Fos expression in OVA-stimulated OT-I cells, but had little effect 
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on modulating Egr2 expression. After approaching a peak expression at 60 minutes, 
the expression of both proteins was stable out to 6 hours. This indicated that ITK/
RLK-inhibited OT-I cells did not “catch up” in c-Fos expression during the time 
course of this experiment and the RNA-seq experiments measured dampened 
expression and not an average of asynchronous cells. Cells that expressed both 
CD69 and Egr2 also displayed a graded amount of c-Fos expression dependent on 
the TCR stimulation strength and ITK/RLK-inhibition (Fig. 6D). These results also 
confirmed that ITK/RLK signaling contributes to graded gene expression in 
response to variations in TCR signal strength.
NF-κB inhibition produces graded immediate gene expression
To test whether specific inhibition of the NF-κB pathway would also produce 
graded induction of early genes, we treated OT-I cells with either an inhibitor of the 
IκB kinase (IKK) complex, IKK-16, or for comparison, a MEK inhibitor (PD325901) to 
control activation of MAPK (Erk1/2). As expected, neither IKK-16 nor PD325901 had 
an effect on NFAT1 translocation in OT-I cells (Fig. 7A-B), but treatment with IKK-16 
tuned NF-κB (p65) translocation and treatment of PD325901 effectively inhibited p-
Erk (Fig. 7A-B). OT-I cells treated with moderate concentration of IKK-16 or 
PD325901 exhibited dampened c-Fos expression (Fig. 7C-D). As expected, Egr2 
expression was also dampened by PD325901 treatment, but less affected by IKK-16 
treatment. At some concentrations of IKK-16, Egr2 expression is largely unchanged 
but c-Fos expression is reduced two-fold (Fig. 7C, E). These experiments indicate 
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that induction of select immediate genes, such c-Fos, are more dependent on the 
strength of NF-κB induction during activation. 
DISCUSSION
Our results provide evidence for a hierarchy of signaling thresholds for 
pathways downstream of the TCR and ITK. NFAT, MAPK, and NF-κB signaling all 
exhibit varying patterns of activation in single naïve OT-I cells after stimulation 
with OVA peptide or altered OVA peptide ligands. We revealed NF-κB p65 
translocation is uniquely sensitive to the quality of peptide:MHC interaction and 
ITK/RLK activity. Our findings also demonstrated that diminished NF-κB signaling 
due to ITK/RLK inhibition has transcriptional effects in stimulated T cells, in that 
NF-κB response genes and induced AP-1 gene family (Fos, Fosl1, Fosb) members are 
diminished in abundance compared to untreated cells.
Most models of TCR initiation describe receptor proximal signaling as digital 
and inherently noisy. In order for successful TCR signaling to result in changes to 
transcription factor activation in the nucleus, pathways must produce stable 
intermediates only after repeated and sustained engagements with peptide:MHC (5, 
11, 61). TCR-induced MAPK activation has been shown to exhibit strong digital 
behavior due to positive feedback regulation of son of sevenless (SOS) which 
sustains active Ras (12, 61). To measure activation of MAPK signaling, we observed 
p-Erk1/2 fluorescence in single cells with flow cytometry. Consistent with previous 
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reports, we measured strongly digital Erk activation in response to TCR ligation 
with peptide:MHC (11, 12). The fraction of cells positive for p-Erk after PRN694 
treatment remained largely unchanged, but the p-Erk fraction was sensitive to 
peptide affinity (Fig. 1F). We expected p-Erk fluorescence to be sensitive to ITK 
activity because DAG production stabilizes SOS activation (12). However, it is 
possible that upstream phosphorylation of LAT after TCR triggering is the rate 
limiting step for MAPK activation rather than the ITK-dependent production of 
DAG. Further, initial experiments with Itk-/- mice reported decreased p-Erk in 
pooled whole CD8+ T cell lysates after stimulation with anti-CD3 antibody (21). In 
contrast, our experiments measure TCR responses after engagement with 
peptide:MHC ligands, which show markedly different kinetics compared to those 
elicited by α-CD3 stimulation.
A separate study previously reported NF-κB behaves digitally after TCR 
stimulation. Direct antibody-mediated stimulation of the TCR in C57BL/6 mouse 
CD4+ and CD8+ T cells or OVA peptide stimulation of CD4+ OT-II cells displayed 
evidence of digital NF-κB activation (13). In the current study, we provide a carefully 
tuned examination of physiological NF-κB responses in naïve CD8+ T cells. Given 
sufficiently strong peptide stimulation (native N4 OVA peptide) or PMA/Ionomycin, 
T cells can quickly and completely translocate p65 with similar kinetics as NFAT1, 
appearing “all or none” (Fig. 1C,E; 2A). Our results reveal however, the strength of 
TCR stimulation the amount of ITK activity produces intermediate, graded states of 
p65 activation during T cell priming. 
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 As we observed that NF-κB signaling was specifically sensitive to PRN694 
treatment, these findings highlighted a role for ITK in amplifying signals induced by 
weaker TCR inputs that could not sufficiently trigger NF-κB on their own, even 
under conditions that stimulate NFAT and Erk. Later during activation, after initial 
priming, combined TCR, CD28, and other co-stimulatory receptors become 
increasingly important in amplifying NF-κB signaling via PI3K (62). It may be 
advantageous for naive cells to limit NF-κB, by making it more difficult to trigger 
with TCR stimulus alone.  Our results reveal however, weaker TCR stimulation or 
ITK/RLK inhibition with PRN694 produces intermediate states of p65 activation, 
which do not appear digital. Robust p65 nuclear translocation requires ITK and 
strong TCR interaction and NFAT1 and p-Erk remain digitally responsive during 
weaker TCR stimulation or PRN694 treatment. These results indicate discrete, 
analog levels of NF-κB activation during T cell priming.
NFAT translocation is exclusively dependent on SOCE activation of 
calcineurin, while NF-κB activation is layered with multiple signaling inputs (50, 63, 
64). ITK and subsequent PLC-gamma-induced production of DAG activates NF-κB 
p65 through PKC-theta (17, 50). PLCgamma production of IP3 generates calcium flux 
and activates calmodulin and subsequently calcineurin, which dephosphorylates 
sequestered NFAT1. Calmodulin also activates calmodulin-dependent protein 
kinases (CAMK), which can stabilize the CARMA complex and ultimately assist in 
NF-κB activation (65). Thus, ITK influences activity of NF-κB by both DAG and IP3 
production. Experiments with ionomycin alone stimulate modest NF-κB p65 
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activation in naïve T cells, albeit lessened compared to TCR stimulation with 
peptide:MHC (Fig. 1E; Fig. 2). We and others describe digital NFAT1 translocation 
and calcium flux in single cells, where a discrete threshold of activation governs an 
all-or-none response (Fig. 1C-D) (7, 9, 10). We attribute the sensitivity and analog 
qualities of NF-κB activation in response to ITK activity to the combinatorial effects 
of simultaneous Ca2+ and DAG signaling (Fig. 2). Indeed, higher NF-κB MFI 
correlates with “switched on” NFAT1 fluorescence, indicating that digital TCR 
initiation and Ca2+ flux may precede NF-κB activation (Fig. 1C, E, F).
            One of the questions driving our transcriptomics and genomics experiments 
was to discern whether ITK activity, and broadly, strength of TCR signal, directs 
diverging transcriptional programs or rather tunes the abundance of transcripts 
within one activation-associated gene set. RNA-seq results revealed that ITK 
inhibition or weaker TCR interactions with lower affinity peptide:MHC induce 
similar genes as strong TCR signaling (Fig. 3). A recent single cell transcriptomic 
study, thoroughly concluded that peptide stimulated OT-I cells activate a single 
effector transcriptional program and resultant effector cells have similar cytolytic 
capacity, independent of TCR signal strength (46). With single cell RNA-seq analysis, 
the same study also showed weaker TCR signaling delays early gene transcription. 
We identified the temporally-induced early gene clusters within 2 hours of TCR 
stimulation, but did not detect similar shifts in transcriptional kinetics due to ITK 
inhibition or weaker peptide affinity, but this is likely a limitation of our pooled 
RNA-seq experiments. In contrast, our analyses of signaling events in naïve OT-I 
cells do show weaker stimulation and ITK inhibition delays onset of peak fractional 
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NFAT responders and NF-κB is only appreciably detectable after 60 mins. 
Additionally, cytometric analysis of CD69, c-Myc, Egr2, and c-Fos display slowed 
expression when stimulated with weak peptide:MHC.
Cooperation of NFAT, AP-1, and NF-κB transcription factors is required for 
many aspects of optimal transcription of T cell activation programming, including 
production of cytokines like IL-2, which was one of the most differentially 
expressed genes due to TCR signal strength or PRN694 treatment after 2 hours 
(Supplemental Fig. 4). Early IL-2 signaling through the induced high-affinity IL-2 
receptor CD25 helps maintain levels of c-Myc, while also lowering the apparent 
TCR signaling threshold (66, 67). Thus, CD8+ T cells that quickly transcribe large 
amounts of IL-2 can maximize their clonal expansion. The IL-2 promoter contains 
NF-κB binding sites and critical NFAT:AP-1 binding sites, where both partners are 
required for transcription (55). In ITK-inhibited cells or during weak signaling, we 
measure reduced NF-κB activation, diminished production of AP-1 transcripts (Fos, 
Fosb, Fosl1), and decreased Fos protein (Fig. 4). These conditions could contribute to 
slower production of IL-2 transcripts, which are among the most sensitive to the 
strength of TCR within 2 hours. There is evidence that T cells may continue to 
accumulate c-Fos protein after serial encounters with APCs during the early 
periods of T cell priming, effectively summing their cumulative duration of signaling 
(68, 69). TCR stimulation that induces efficient NFAT translocation, but not NF-κB, 
and only weakly induces AP-1 factors may suffer from low accumulation of early 
gene products and weak IL-2 production. Chromatin immunoprecipitation assays 
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utilizing a constitutively active NFAT mutant, where NFAT is permanently nuclear, 
shows NFAT cannot bind the IL-2 promoter without its AP-1 binding partner;  in the 
absence of AP-1, IL-2 transcription is abrogated (70).
            A better understanding of the biology of T cell exhaustion is crucial in 
treating chronic illness and maximizing the efficacy of T cell immunotherapies, 
such as CAR-T. Recent work has identified NFAT as an important TCR-dependent 
regulator of T cell exhaustion phenotypes (70-72). NFAT can bind to the promoter of 
select exhaustion-associated genes without its partner AP-1 (70) and drives 
expression of NR4A family transcription factors which further maintain exhaustion 
programming (71, 72). Within the hierarchy of T cell signaling pathways we identify 
here, NFAT and MAPK appear to be more easily stimulated than NF-κB. Our data 
provide further evidence that CD8 T cells may signal through NFAT more easily, 
without complete downstream pathway activation, which could contribute to 
exhaustion phenotypes. 
FIGURE LEGENDS
Figure 1. TCR signal strength and PRN694 regulate graded NF-κB activation 
within digitally NFAT1 and p-Erk active cells. 
(A-B) Histograms depicting CD69, and IRF4 expression after 24 hours (A) or 
CellTrace Violet fluorescence after 48 hours (B) in OT-I cells stimulated with APCs 
plus 100 nM of indicated peptide, with or without 50 nM ITK/RLK inhibitor 
PRN694. (C) Histograms of NFAT1 and NF-κB fluorescence in isolated OT-I nuclei or 
p-Erk1/2 fluorescence in OT-I cells after stimulation with APCs plus 100 nM N4 
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peptide stimulation for 1 hour. (D) Histograms of NFAT1 and NF-κB fluorescence in 
isolated OT-I nuclei or p-Erk1/2 fluorescence in OT-I cells after stimulation with 
APCs plus 100 nM T4 peptide for the indicated times. (E) Histograms of NFAT1 and 
NF-κB (p65) fluorescence within OT-I nuclei isolated after 1-hour stimulation with 
APCs plus 100 nM N4 OVA peptide or PMA (10 ng/mL)/Ionomycin (1 µM) addition. 
(F) Line plots depicting either NFAT1 or NF-κB fluorescence within OT-I nuclei or 
p-Erk fluorescence in OT-I cells over 2-hour stimulation with APCs plus 100 nM of 
indicated peptide with or without 50 nM PRN694. Histograms to the right 
represent nuclear or whole cell fluorescence patterns after 60 minutes of 
stimulation. (G) Histograms depicting NF-κB (p65) fluorescence within NFAT1+ 
nuclei after 1-hour stimulation in conditions as in A, B and E. (H) Line plots of 
change in normalized NFAT1 MFI (%) or normalized NF-κB (p65) MFI (%) within 
NFAT1+ OT-I nuclei after 1-hour stimulation with APCs plus 100 nM N4 or T4 OVA 
peptide, in the presence of titrated concentrations of PRN694. Histograms shown 
are representative of 3 or more independent experiments.
 
Figure 2. PMA and ionomycin supplementation during peptide stimulation 
reveals synergistic NF-κB signaling activation.
(A) Histograms depicting NFAT1 and NF-κB (p65) activation during 1 hour 100 nM N4 
stimulation with (red) or without (blue) 50 nM of PRN694 or received no peptide 
stimulation (dark grey). 1 µg/mL ionomycin or 12.5 ng/mL PMA was supplemented 
to wells were indicated. (B) FACS contour plots with adjust histograms comparing 
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NF-κB (p65) and NFAT1 fluorescence in after the same stimulation conditions as in 
A, but with 100 nM T4 peptide stimulation.  
 
Figure 3.  Inhibition of ITK dampens immediate TCR signaling-induced 
transcripts.
(A) Heatmap depicting mean variance-stabilized transformed (VST) normalized 
expression values of top 357 genes (Log2 fold-change > 2, mean expression > 1000, 
p-adj < 0.1) induced in OT-I CD8+ T cells at three timepoints (30, 60, and 120 
minutes) after stimulation with APCs plus 100 nM N4 OVA or T4 altered OVA 
peptide with or without 50 nM PRN694. Genes were grouped with k-means 
clustering into 6 clusters. (B) Line plots depicting Z-score of 2-hour expression 
time course of gene clusters identified in A. Scores for mean expression values for 
each cluster are grouped by conditions in A; N4 (blue), N4 + PRN694 (red), T4 
(orange), T4 + PRN964 (green). Total expression data for all conditions from three 
replicates are drawn in gray. (C) Enriched MSigDB signatures in gene clusters 
identified in A. Log10 transformed adjusted p-values (FDR) of (up to) the top 5 terms 
(p-adj. ≤0.05) from both “Hallmark Gene Sets” and “Immunologic Signatures” 
MSigDB collections. Cluster VI did not contain gene set enrichments with these 
constraints. Data represent three separate biological replicate experiments each 
utilizing pooled splenocytes from three or more OT-I mice. 
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Figure 4. Immediate transcripts are differentially sensitive to PRN694 
treatment.
(A-B) Volcano plots identifying transcripts sensitive to 50 nM PRN694 treatment 
measured after 30 stimulation of OT-I cells with APCs plus 100 nM N4 peptide (A) or 
100 nM T4 peptide (B). Labeled gene names represent select early-induced 
transcripts significantly expressed compared to unstimulated controls, extracted 
from either clusters I or II from Fig. 4.2. Plots depict the Log2 fold change of 
normalized expression of untreated samples over PRN694-treated samples against 
-Log10 transformed FDR values. Data points and gene names significantly above FC 
cutoffs (Log2 fold change > 1, -Log10 FDR <0.1) are drawn in red; genes that were not 
significantly differentially expressed due to PRN694 treatment are drawn in gray. 
Figure 5. Early ITK-dependent changes in DNA accessibility are enriched for 
NF-κB and AP-1 binding motifs.
(A) Distribution of ATAC-seq fragment distance from peak centers. Comparison of 
120-minute stimulation with N4 peptide (blue) and unstimulated OT-I nuclei (grey). 
(B) Volcano plot of differentially-accessible genomic peak regions after 30 minutes 
of stimulation with N4 peptide. (C) Volcano plot of differentially accessible peak 
regions due to PRN694 treatment after 30 minutes of N4 peptide stimulation. 
Annotations of closest gene TSS are labeled for select regions. For B and C, 
significantly differentially accessible regions (Log2 fold change < -1 or > 1 and p-adj < 
0.1) are drawn blue. (D) Heatmap and HOMER de novo motif enrichment analysis of 
k-means clustered Log2 transformed and row-scaled peak regions after 30 min of 
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either 100 nM N4 or T4 peptide stimulation with or without 50 nM PRN694 (N4 
untreated, blue; N4 + PRN694, red; T4 untreated, orange; T4 + PRN694, green). 
Displaying top (p-adj < 10-50) motifs for each cluster. (E-F) ATACs-seq genomic tracks 
for regions around Irf4 and Fosb loci comparing different peptide and PRN694 
stimulation conditions after 30 minutes. Also plotted are ionomycin or ionomycin + 
PMA stimulation ATAC-seq peaks and NF-κB ChIP-seq peaks (Mognol et al, 2017; Oh 
et al., 2017). Differential experimental ATAC-seq peaks are highlighted in yellow. 
Figure 6. TCR signaling and ITK control graded accumulation of early gene 
product c-Fos. 
(A) Line plots of mean normalized expression counts of select induced transcripts 
measured at 0, 30, 60, and 120 min similar to Fig. 4.4. (B-C) Line plots (B) and 
representative histograms (C) of flow cytometry results for gene products of 
transcripts profiled in A. Experiments were conducted under similar stimulation 
conditions and previous figures and stimulated up to 6 hours. Results are plotted as 
% positive or normalized to maximum MFI (% max MFI) where indicated. (D) 
Representative histograms depicting graded c-Fos fluorescence in CD69+ Egr2+ OT I 
cells in response to different stimulation conditions measured after 6 hr. Labeling is 
consistent: N4 - blue (circles), N4 + PRN - red (squares), T4 – orange (diamonds), T4 
+PRN694 – green (triangles). Data represent three biological replicates. Error bars 
indicate s.e.m.  
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Figure 7. Specific NF-κB inhibition differentially reduces c-Fos protein 
accumulation. 
(A-B) Histograms depicting effect of titration of IKK-16 (A) or PD325901 (B) on 
NFAT1, NF-κB, and p-Erk1/2 activation after 1-hour simulation with N4 peptide. (C) 
Histograms demonstrating the effect of 500 nM IKK-16 or 1000 nM PD325901 on c-
Fos, Egr2, and CD69 protein expression in OT-I cells stimulated with N4 peptide for 
2 hours. (D-E) Line plots of depicting 500 nM IKK or 1000 nM PD325901 treatment 
on c-Fos (D) and Egr2 (E) protein accumulation over 4 hours stimulation with N4 
peptide. Compiled are three separate experiments, error bars are s.e.m.
Supplemental Figure 1. PRN694 differentially affects NF-κB and NFAT1 
responses during variable peptide stimulation.  
(A-B) Line plots depicting NFAT1 or NF-κB (p65) activation in OT-I nuclei in 
response to 30 minute stimulation by WT splenocytes loaded with indicated doses 
of N4, T4, or G4 peptide, with or without treatment with 50 nM PRN694. Error bars 
indicate s.e.m. 
Supplemental Figure 2. RNA-seq replicate correlation and principal 
component analysis. 
(A) Sample-to-sample correlation to compare RNA-seq replicates. (B-D) Principal 
component analysis of all RNA-seq replicates across all stimulation conditions. 
Supplemental Figure 3. Graded TCR signaling induces a single transcriptional 
program. 
34
(A-C) Indicated overlap of induced genes identified in each tested TCR signaling 
condition. N4 = blue (n=487), T4 = orange (n=284), N4 + PRN694 = red (n=390), T4 + 
PRN694 = green (n=122). (D-E) The effect of stimulation with weaker affinity peptide 
vs treatment with PRN-964. Linear correlation of Log2 fold-change values 
determined by differential expression analysis of either N4/N4+PRN694 or N4/T4 
comparisons at each time point. 
Supplemental Figure 4. Example patterns of detected early transcripts. 
Line plots depicting normalized count data of selected gene transcripts over the 
course of the 2-hour RNA-seq experiment. Colors are consistent with other figures. 
Data represent three separate biological replicates. All genes presented are 
significantly differentially expressed compared to control at least at one time point. 
Error bars represent s.e.m. 
Supplemental Figure 5. Data summary of TCR signal strength effects on 
activation of separate signal pathways. 
(A) Line plots depicting how ITK disproportionately shifts signaling thresholds. 
MAPK, NFAT, and NF-κB responses are drawn in blue, green, and, red respectively. 
Activation response when ITK is present is drawn in a lighter shade; activation 
without ITK is drawn in a darker shade. Direction of the shift due to presence of ITK 
is indicated with an arrow. “TCR Stimulation” input is plotted against the resultant 
degree of “Activation.” (B) Summary of TCR signal strength control of pathway 
activation within a stimulated population. Groups of curves representing single cell 
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MAPK (blue), NFAT (green), and NF-κB (red) responses to either “strong” (light 
shade) or “weak” (dark shade) stimulation are presented over time. Histograms to 
the right represent average “snapshots” of pathway activation of the populations in 
the line plots. 
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